FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

39300911000001108: Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Apr 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1138381000001113 Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1138391000001110 Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Has AMP Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) true Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Is a Avatrombopag 20mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Has specific active ingredient Avatrombopag maleate false Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Avatrombopag false Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Has specific active ingredient Avatrombopag maleate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start